The Promise of NIH ENGAGE

Dr. Lyric Jorgenson (l) has co-authored this blog with Dr. Suzanne Bakken (c) Ms. Chrstin Veasley (r). Dr. Bakken is a Professor of Biomedical Informatics at Columbia University.  Ms. Veasley is the co-founder and Director of the Chronic Pain Research Alliance.  Dr. Bakken and Ms. Veasley also serve as the co-chairs of the NIH ENGAGE Working Group.

I’m sure many of you have heard the old joke “Why do we park on driveways and drive on parkways?” Sometimes the English language just doesn’t make sense. Other times, however, it feels completely intuitive. Take for instance, the word “engage.” Just speaking the word aloud feels like a call to action. Appropriately, NIH launched its new ENGAGE initiative to be just that – a call to action for people and their communities to participate in the design and conduct of clinical research.

Traditionally, those who could benefit the most from clinical research have had the least involvement.  The ENGAGE initiative aims to flip this script by making public involvement in clinical research the rule and not the exception. By amplifying public voices, both healthy and sick, scientists can design more meaningful research studies and all Americans can benefit from the investment. 

The team tasked with making this vision a reality consists of a diverse set of motivated experts with many practical hands-on experiences, including patients, advocates, researchers, clinicians, non-profit organizations, and of course, members of the public.  They’ll be working to develop a bold strategy for maximizing public involvement throughout the clinical research continuum for NIH’s consideration.    

We cannot stress enough the prominent role that public outreach and community dialogue will play in the ultimate success of ENGAGE.  At this point, you might be asking yourself how we are planning to take on such an enormous task. First, we are shouting from the rafters that ENGAGE is open for business and we want to hear from you.  To help promote awareness, NIH has launched an ENGAGE website which contains case studies on NIH’s approach to engagement, information on team members, details on planned events, and much more.

The second part requires you – “engagement” is a two-way street!  We need everyone to help us spread the word about ENGAGE.  To get us started, NIH has released a request for community information to share the team’s vision and help us get a sense of your thoughts on these issues. Tell your co-workers, your neighbors, your friends, and anyone else who will listen that NIH wants to hear from you!

An essential pillar of our work will be to interact with people in ways, and in places, where they feel comfortable.  This means that it is vital for the team to visit communities across the country to hear your stories and needs first-hand.  The success of ENGAGE will be built on a robust program of public involvement in people’s own communities. We anticipate these listening sessions to kick-off in late 2024 and details will be provided on the ENGAGE website as soon as they are available.

We expect a lot of progress over the course of the next year so stay tuned. Also, to learn more, please tune into the upcoming Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) on June 17th as we will be discussing more on our planned efforts, including an upcoming webinar on July 17th.

This is just the start of a very exciting activity.  The ENGAGE initiative holds tremendous potential, but we need your help.  By creating a respectful space where all perspectives are welcome, we can work together to ensure that ENGAGE = better health for everyone.

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric

NIH to Host Webinar on Draft NIH Intramural Research Program Policy: Promoting Equity through Access Planning

NIH will be hosting an informational webinar about its recent request for information (RFI) and draft proposal to incorporate patient access planning in the commercialization process for NIH-owned inventions.

The webinar will take place on Tuesday, June 11, 3:00 pm – 4:00 pm ET. Presenters will provide background on NIH’s Intramural Research Program, discuss patent licensing at NIH, review the concept of access planning, and discuss the RFI and draft policy proposal.

Individuals and organizations interested in learning about the RFI and gaining a better understanding of the NIH Intramural Research Program’s patent licensing process are encouraged to attend. This webinar is free of charge though pre-registration is required. Participants are invited to submit questions for NIH to address during the webinar. Participant questions must be received by Friday, June 7, 2024.

Information on the agenda, how to register, and how to submit questions can be found on the event website.

If you are not yet a subscriber to this listserv, please sign up here. Questions may be sent to [email protected]. Also, please consider following us on Twitter @NIH_OSP

Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity in Access Planning

NIH is proposing to develop and implement a new policy within the NIH’s Intramural Research Program, the internal research arm of the agency. The policy would require organizations partnering with NIH through a patent licensing agreement that succeed in bringing certain products to market to submit a plan outlining steps they intend to take to promote patient access to any resulting drug, biologic, vaccine, or device. NIH seeks input on this draft policy and accompanying draft license agreement language that incorporates patient access in the commercialization process for NIH-owned inventions.

NIH will use the responses to this request for information to develop a final policy. Comments on the proposed policy must be submitted at: https://osp.od.nih.gov/comment-form-draft-nih-intramural-research-program-policy-promoting-equity-through-access-planning.  Comments must be received by July 22, 2024.

In addition, NIH will be hosting an informational webinar on the proposed policy on June 11, 2024.  More information on the agenda and how to register will be provided shortly.

For additional context on the benefits of access planning, please see NIH’s 2023 Workshop on Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.

Questions may be sent to [email protected]. Also, please consider following us on Twitter @NIH_OSP

OSP Celebrates Clinical Trials Day; Releases New Resource Related to Consent Language for Studies Using Digital Health Technologies

Today, May 20th, is Clinical Trials Day; a day to reflect, recognize, and celebrate all that has been achieved through clinical trials and the participants, communities, researchers, clinical staff, and others who make these accomplishments possible.  Clinical trials are at the heart of all medical advances.  On behalf of OSP, thanks to all those who make clinical research possible.

As we look to the future of clinical research, advances in digital health technologies are providing new opportunities to bring trials to participants.  To assist in the responsible deployment of these technologies,  OSP, through an NIH-wide collaboration, has developed and released Informed Consent for Research Using Digital Health Technologies: Points to Consider & Sample LanguageThis resource presents general points to consider, instructions for use, and optional sample language for the research community. This resource will best be used to inform research teams and Institutional Review Board (IRB) members who are planning, reviewing, or conducting research that studies or uses digital health technologies.

Questions about this resource can be sent to [email protected]

If you are not yet a subscriber to this listserv, please sign up here.   Also, you can follow us on X @NIH_OSP and LinkedIn.